chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Burning sensation right after the injection and into the next day. Really hard raised knot and warm at site of injection, itchy and reddish. No fever, No numbness, No tingling. No S.O.B. or other Breathing issues. has soreness but good R.O.M. Feels tired. Patient states using Ibuprofen which helps. Advised to use cold packs to site but no ice packs. 30 minutes on the off and rotate.. She did state today she noticed what appears to be puss pockets. Advised to watch for infection. if condition worsens seek her PCP for advised or examination or call local ER if after hours. She states understanding.
really bad diarrhea  which lasted for about 5 days; swelling at the site; a little bit of fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (really bad diarrhea  which lasted for about 5 days), VACCINATION SITE SWELLING (swelling at the site) and PYREXIA (a little bit of fever) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00SC212) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced DIARRHOEA (really bad diarrhea  which lasted for about 5 days), VACCINATION SITE SWELLING (swelling at the site) and PYREXIA (a little bit of fever). At the time of the report, DIARRHOEA (really bad diarrhea  which lasted for about 5 days), VACCINATION SITE SWELLING (swelling at the site) and PYREXIA (a little bit of fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jun-2021, Body temperature: 101 (Inconclusive) 101.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant products and treatment medication were reported.   This case was linked to MOD-2021-231256 (Patient Link).
pt recvd vax on 15nov94; Lt upper arm swelling & warmth on 29nov94; meds given; all resolved by 28nov94;
Patient received a flu vaccine on 9/11/22 at pharmacy. Patient did not report this at time of administration. This was discovered on billing.
Rash developed in middle front of torso starting at 7am and progressively got worse to mostly cover front and back of torso and on left arm down to shot location.  Rash doesn?t go to neck or below waist.  Rash is itchy and then burns.    It?s now 8:30 and still spreading.  Using Triamcinolone acetonide cream .1% to ease itch and burn.
Patient received an expired dose of engerix-b; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received HBV (Engerix B) (batch number D423N, expiry date 1st June 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 11th August 2022, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 11th August 2022, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-AUG-2022 Reporter's Comment: The reporter was a nurse. The reporter reported that the patient received an expired dose of Engerix-B. The reporter consented to follow up.  Additional supportive information: The patient received a Engerix-B which was already expired, which led to expired vaccine used.
Patient had a severe local reaction according to walk-in dr. 2 by 3 inch red area, hot and swollen. No rash.
Burning sensation with tingling and some minor numbness within 5 min, within 15 min started to feel dizzy.  spoke with EMT on site and was told I could remain for an additional observation before returning home and that another 5 people had the same symptoms that morning and appeared to be fine after some time.  After I arrived home, on or about  10: 45, I ate an egg sandwich and the dizzy sensation faded. However, severe fatigue set in  and by 1 PM I went to lie down.  On or about 1:30PM, I awoke with severe chills and a fever of 101.5.    The Chills lasted from about until about 3AM on April 9th.  The fever, however, went down after I took Tylenol at about 8PM.  I remained in bed on April 9th until 8AM and proceeded to work from home with fatigue and a headache that would not go away with Advil.  By April 10th the a majority of the initial symptoms abated and only a sore left arm with a slight tingling sensation remained.  On Sunday, April 11th, my right ankle started to swell and left leg had some pain (behind the knee) .   Elevated the leg and the swelling went down on the right ankle and left leg felt better after massage on the 12th.
Information has been received from a licensed practical nurse concerning an 18 month old child (gender not reported) who in February 2007, "sometime this past week" was accidentally vaccinated with Pneumovax 23 (lot # not reported) 0.5 ml injection.  In February 2007, the patient was accidentally administered Pneumovax 23 instead of PREVNAR.  No adverse experience occurred in the patient.  No additional information was available at the time of reporting.  Additional information was received from the licensed practical nurse via telephone call.  The nurse reported that two different people were helping with the vaccinations.  The vaccines were close together and the person picked up the wrong vaccine.  To prevent a recurrence, a two check system has been put in place.  No additional information is expected.
Heart rate of 136; chills; shaking uncontrollably; This is a spontaneous report from a contactable healthcare professional. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced heart rate of 136, chills and shaking uncontrollably on an unspecified date. The events took place after use of product. The patient went to the ER and was treated. Therapeutic measures were taken as a result of heart rate of 136, chills and shaking uncontrollably. The outcome of the events was unknown.  No follow-up attempts are possible. Information about Lot/Batch cannot be obtained.
patients were vaccinated with expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients were vaccinated with expired doses) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients were vaccinated with expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients were vaccinated with expired doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. It was reported that pharmacist thought that the vaccine was expired in Jun-2022, however it was expired on 01-Apr-2022.  No treatment information was reported.
This case was reported by a healthcare professional and described the occurrence of diaphoresis in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of FLULAVAL (unknown). At an unspecified time after vaccination with FLULAVAL, the subject experienced diaphoresis, chest pain, shortness of breath and fatigue. The healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting the outcome of the events was unspecified. Four additional subjects had similar symptoms. Linked cases include: A0751890A, A0751892A, A0751893A and A0751895A. Linked case A0751880A was more severe and included subject and event specifics.
Myalgias started 3-4 days ago (03/27): right sided chest wall pain started Sunday morning radiation to back: EKG shows new intra ventricular conduction defect: echocardiogram nl
chills,muscle aches accross shoulders,tiredness lesding to atrial fibulation after 3 days
pt recvd vax & w/in 24 hrs pt devel erythema, tenderness & warmth approx 1" below inject site; size of react 2" x 2";
About 12 hours after vaccine, noticed some vague nausea, abdominal discomfort and chills; this was at bedtime. I woke up a couple of times, noticed chills once and next time I woke, I was hot. Felt better initially in AM, but noticed lack of appetite, nausea, muscle aches (lower back), fatigue, but most concerning was feeling of anxiety, irritability, and unease. As the day progressed, these symptoms subsided. The next day I still felt fatigued.
Information has been received from a certified medical assistant concerning an adult female patient who on an unknown date was vaccinated with a dose of PNEUMOVAX vaccine (Lot #660717/0224X). Subsequently, the patient could not move her arm and was treated with steroid injection. At the time of reporting the patient was recovering. The certified medical assistant reported that the last year they never received any adverse reaction complaints and this year they had already received five complaints. The reporter has requested a lot check. In follow up the medical assistant reported that the patient was vaccinated on 29-SEP-2008. In approximately September 2008, the administered right arm was a painful reaction. The patient had to be injected with KENALOG. The patient was back in the office on 22-OCT-2008 reporting numb hand and arm. The patient's painful arm and numb hand and arms persisted. The medical assistant still administered additional patients using lot # 660717/0224X. However, she now administered it in the patients' hips instead of arms. No adverse events have been reported after she changed injection sites. A standard lot check investigation was performed. All in process quality checks for the lot number 660717/0224X was satisfactory. The lot number 660717/0224X met the requirements of the Center and was released. This is one of several reports provided by the same source. Additional information has been requested.
Dizziness, Arthralgia, Fever, NauseaVomiting, injection site pain, chills, fatigue Narrative:
bump on my left index finger popped up/ I was told it was osteoarthritis; pain while walking and going up stairs; welt, that was a size of a softball, but flat; Fever; Body ache; Tired; Left knee pain/shoulder pain; ganglion cyst; welt size of softball on arm/bump on index finger; ringing in left ear; rash; This spontaneous case was reported by a consumer and describes the occurrence of SYNOVIAL CYST (ganglion cyst), PERIPHERAL SWELLING (welt size of softball on arm/bump on index finger), TINNITUS (ringing in left ear), OSTEOARTHRITIS (bump on my left index finger popped up/ I was told it was osteoarthritis) and PAIN IN EXTREMITY (pain while walking and going up stairs) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Allergy to Sulfur antibiotic- Rash all over body, swelling, itchy and throat closing) since 2018. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Nasal congestion.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced SYNOVIAL CYST (ganglion cyst), PERIPHERAL SWELLING (welt size of softball on arm/bump on index finger), TINNITUS (ringing in left ear), RASH (rash) and ARTHRALGIA (Left knee pain/shoulder pain). On an unknown date, the patient experienced OSTEOARTHRITIS (bump on my left index finger popped up/ I was told it was osteoarthritis), PAIN IN EXTREMITY (pain while walking and going up stairs), URTICARIA (welt, that was a size of a softball, but flat), PYREXIA (Fever), MYALGIA (Body ache) and FATIGUE (Tired). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form and MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) at a dose of UNK dosage form. At the time of the report, SYNOVIAL CYST (ganglion cyst), PERIPHERAL SWELLING (welt size of softball on arm/bump on index finger), TINNITUS (ringing in left ear), OSTEOARTHRITIS (bump on my left index finger popped up/ I was told it was osteoarthritis), PAIN IN EXTREMITY (pain while walking and going up stairs), URTICARIA (welt, that was a size of a softball, but flat), RASH (rash), PYREXIA (Fever), ARTHRALGIA (Left knee pain/shoulder pain), MYALGIA (Body ache) and FATIGUE (Tired) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-154482 (E2B Linked Report). This case was linked to MOD-2021-153684 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Significant follow up appended- Patient demographic details, Past Medical history, Concomitant medications and new Events updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-154482:Crosslinked case of reporter second dose
experiencing increasing muscles pains from the waist down to his leg on the right side; his right arm was sore for the first two days but that has went away; This is a spontaneous report from a contactable consumer. A 76-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route administration at arm right on Jan2021 at first dose single for COVID-19 immunization. Medical history and patient's concomitant medications were not reported. The patient experienced increasing muscles pains from the waist down to his leg on the right side, his right arm was sore for the first two days but that has went away on an unspecified date. It was reported that, caller stated he received the first dose of the Pfizer COVID vaccine last Wednesday and as the days have gone on he has been experiencing increasing muscles pains from the waist down to his leg on the right side. Caller stated he received the vaccine on the right arm. Caller stated he has not worked out in many years and the muscle pain feel similar to what it feels like after you have worked out. Caller stated after receiving the injection his right arm was sore for the first two days but that has went away and he only has muscle pain from his butt and trunk area down to his leg. Caller would like to know if his symptoms are normal and what he should do regarding his second dose that is scheduled a week from next Wednesday. The outcome of event experiencing increasing muscles pains from the waist down to his leg on the right side was unknown, while the other event was recovered.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
No additional AE was reported; Improperly stored vaccine was administered to a patient; This spontaneous report was received from a medical assistant referring to a 5-year-old patient of unknown gender. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.   On 27-JUL-2020, the patient received an improperly stored dose of  measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) (dosage regimen was not provided) lot # S030093, expiration date 24-MAR-2021 for prophylaxis. The improperly stored dose experienced a temperature of -11.17 degree Celsius (°C) for 19 hours, with a previous temperature excursion of -11.77 °C for 2 hours, and the call was because of a data logger. No additional adverse effects reported.  This is one of 2 cases received from the same reporter.; Sender's Comments:  US-009507513-2007USA010881:
I had a tightness in my chest, sore throat, coughing up mucus that was yellow or brown. I made an appointment with my doctor's office to go in and discus my symptoms. They ran both a COVID-19 and Influenza A and B test they both came back negative. I was diagnosed with bronchitis, I was prescribed amoxicillin, Z-PAK, and benzonatate. Three after starting the medication I started to feel better.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:01/12/21,pfizer,Lot#EL3248 2nd dose:02/02/21 Pfizer,Lot# EN5318 Diagnosed covid positive:04/19/21 Exposure:Home exposure Symptoms:Cough,loss of smell/taste,Diarrhea,sore throat,runny nose,body aches,fatigue,feeling foggy,fever(subjective)
Right axillary, supraclavicular, cervical, precarinal and hilar lymphadenopathy with soft tissue swelling of the right axilla/chest wall, right upper lobe opacity, numbness of the right arm and right face. Improving as of 8/2/2021.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A, 029A21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021 at 1:13 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021 at 1:21 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication were reported.  No treatment medication were reported.  Moderna vaccine 044A21A expired on 31 Aug 2021. Vaccine administered to client on 01 Sep 2021 as a third dose.
shivering on his bottom lip, kind of like muscle spasms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2), administration date 24Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCLE SPASMS (non-serious), outcome "unknown", described as "shivering on his bottom lip, kind of like muscle spasms". Additional information: about 3 days the patient had shivering on his bottom lip, kind of like muscle spasms.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Since covid shot has been tired all the time and hands hurt worse, ankles hurt and breast bone too. Not like her usual pain
Patient has 3 profiles in system with 2 different phone numbers. Patient presented to clinic on 8/20/21 to get second dose of Pfizer vaccine. When she presented her card she gave a card with her name and a Janssen lot number. Patient was asked by clinic nurse, if she had told the previous nurse about this dose and she stated no she had not. Vaccinator spoke with clinic manager who called clinic doctor and 2nd dose of Pfizer was NOT give. On 3/5/2021 patient was given Janssen lot number 1802068. Then on 7/30/21 the 1st dose of Pfizer vaccine was given (see lot number above).
Myalgias, fever to 101, mild headache and mild cough all started within 24 hours of vaccine.
6/15 evening fever of 99.3 to 102 continuing into 6/16. Developing rash on legs, arms, none on trunk. 6/17 rash redder, itching, mom gave Benadryl helped the itching. Rash stayed, 6/21 rash fading.
Red swollen welt from armpit to just pass elbow. Muscle & joint pain & chills, tired. Slept for 2 days. Welt lasted 1 week.
Patient received a dose after BUD of punctured vial. Vial was left at room temperature after 1st vaccine given. Approximately 4.5 hours later the 2nd dose was given.
chest pain; shortness of breath; HEADACHE; CHILLS; A spontaneous report  was received from a Consumer concerning a 41-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, chills, chest pain, shortness of breath.  The patient's medical history was not provided. Concomitant medications reported were Supplements for unknown indication.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient experienced the event(s) headache . On 23 Jan 2021, the patient experienced the event(s) chills . On 23 Jan 2021, the patient experienced the event(s) chest pain . On 23 Jan 2021, the patient experienced the event(s) shortness of breath.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), headache was unknown.The outcome of event(s), chills was unknown.The outcome of event(s), chest pain was unknown.The outcome of event(s), shortness of breath was unknown..
This spontaneous report was received from a pharmacist regarding a 51 year old male patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unspecified date, the patient was vaccinated with ZOSTAVAX, (unknown dose, strength, lot and expiration) intramuscularly in the left arm. The pharmacist reported that the patient started experiencing numbness, tingling and left sided weakness on an unspecified date, eleven hours after receiving ZOSTAVAX. The pharmacist could not confirm the route of administration however intramuscular route of administration was documented by an unknown source. The pharmacist reported that the patient was hospitalized at an "outside hospital" on an unspecified date and was transferred and hospitalized to other hospital from 14-APR-2016 to 17-APR-2016 to rule out stroke. The pharmacist reported that the patient experienced significant disability as the patient's left arm was flaccid and also stated that the patient was still "complaining of left arm weakness but is improving". The outcome of numbness, tingling, left sided weakness, and stroke was recovering. The causality was not provided by the reporter. The reporter considered the events numbness, tingling, left sided weakness and left arm was flaccid to be serious due to disability. Upon internal review, left sided weakness was determined to be medically significant. Additional information has been requested.